Afpedia > Suppliers > Chemicals > Biochemical Industry > Finished Medicine > Changchun Zhuoyi Biological Co., Ltd

Changchun Zhuoyi Biological Co., Ltd

The strain of rabies virus CTN-1V is produced as the virus species. The homology of CTN strain and nucleotide of various strains in China is 82% to 93%, homology between which is greater than that of other vaccine strains, and more suitable for domestic use in China. Adopt the world's leading U.S. NBS bioreactor Adopt the large-scale cultivation process of world’s leading U.S. NBS40L biorea...

Product Category

Contact Information

Contact: ******
Phone: ******
Email: ******
Location: ******

> Company Profile

Located in Economic Development Zone, Shuangyang District, Changchun. Changchun Zhuoyi Biological Co., Ltd. is a key vaccine manufacturing company in Jilin province invested by Zhejiang Serkoning Biotechnology Co., Ltd.Founded on Jan. 27th, 2005, Zhuoyi Bio is with a registered capital of 95.08 million yuan and a total area of 41,600 square meters. It has a leading domestic vaccine research and development and production capabilities.Changchun Zhuoyi Biological Co., Ltd. devotes to the R&D, manufacture and sale of new-type vaccine. Biological product currently approved in the company is Freeze-dried Rabies Vaccine (Vero Cell) for Human Use. Zhuoyi Bio successfully passed the two-in-one inspection and obtained registration approval and GMP certificate at the end of 2016. Officially put into production in Jan., 2017. The company's exist...More>

> Featured Products

Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried
US $4-6